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Background: Despite the advances of percutaneous coronary intervention (PCI),
suboptimal reperfusion can be caused by microcirculatory damage and distal embo-
lization of plaque and/or thrombus in acute myocardial infarction. Therefore, we
investigated the predictors of microcirculatory dysfunction and subsequent clinical
outcomes in patients with ST-elevation myocardial infarction (STEMI).
Methods:We performed successful primary PCI under the intravenous administration
of nicorandil 12mg for 337 consecutive patients with STEMI. Data on ST-segment
resolution (STR) on electrocardiography, which reveals the restoration of myocardial
perfusion at the microcirculatory level, and the incidence of adverse cardiac events
deﬁned as cardiac death or hospitalization for congestive heart failure were analyzed.
Results: Table lists odds ratio for prediction of complete ST-segment resolution. Also,
the complete STR rate decreased with a signiﬁcant trend across increasing number of
metabolic syndrome components (Cochran Armitage Chi-square, p ¼ 0.007).
Furthermore, metabolic syndrome and baseline anemia remained independent
predictors of adverse cardiac events on multivariate Cox proportional hazard analysis
[hazard ratio 2.44 (95% conﬁdence interval (CI): 1.05 to 5.56, p ¼ 0.01) and 2.58
(95% CI: 1.01-6.60, p ¼ 0.048), respectively].
Conclusions: Metabolic syndrome and baseline anemia are independently related to
microcirculatory impairment and subsequent poorer prognosis. Clustering of risk
factors for cardiovascular diseases and the decreased oxygen delivery might exacer-
bate microvascular function.TCT-607
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Background: Sex-speciﬁc differences affect the evaluation, treatment and prognosis
of coronary artery disease. We tested the hypothesis that long-term outcomes of
fractional ﬂow reserve (FFR)-guided percutaneous coronary intervention (PCI) are
different between women and men.
Methods: Consecutive 1090 patients, referred for PCI and undergoing FFR
measurements at the Mayo Clinic between October 2002 and December 2009, were
included in this registry study. Clinical events were compared between the genders
during a median follow up of 50.9 months.
Results: Of all patients, women had higher FFR adjusted by visual coronary stenosis
than men (P¼0.03). The Kaplan-Meier percent of major adverse cardiac events at 5
years was 35% in women and 38% in men (P¼0.54). Interestingly, in patients
undergoing PCI with an FFR less than 0.75, the incidence of death or myocardial
infarction was signiﬁcantly higher in women than in men (Hazard ratio [HR] 2.16,
95% conﬁdence interval [CI] 1.04-4.51, P¼0.04). Moreover, compared to patients
with FFR >0.80, deferral of PCI for those with FFR between 0.75 and 0.80 was
associated with an increased rate of major adverse cardiac events, particularly death or
myocardial infarction in women (HR 3.25, 95% CI 1.56-6.74, P¼0.002) and revas-
cularization in men (HR 2.66, 95% CI 1.66-4.54, P<0.001).B184 JACC Vol 62/18/Suppl B j October 27–NovemConclusions: Long-term outcome differs between women and men undergoing FFR-
guided PCI. Our data suggest that the sex-based treatment strategy is necessary to
further optimize prognosis of patients with coronary artery disease.
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Background: Fractional ﬂow reserve (FFR) is the reference standard to establish the
presence of ischemia across a coronary stenosis. A “positive” FFR 0.8 is an adverse
prognostic sign, but few data are available on outcomes in coronary stenoses where
the FFR is “negative” (>0.8) and revascularisation subsequently deferred. The aim of
this study was to retrospectively evaluate clinical outcomes in a large cohort of
patients with a negative FFR.
Methods: Consecutive patients (n¼8340) referred for percutaneous coronary inter-
vention (PCI) at our institution between November 2005 and February 2011 were
included. 1783 (18.5%) had undergone FFR assessment. Of these, 788 patients (828
native, previously untreated coronary arteries) had an FFR >0.8. This group, with
a mean age of 69.4 years (36% aged >75 yrs), was examined for MACE (revascu-
larisation, myocardial infarction (MI), all cause mortality, cardiac death) over a mean
duration of 1220 days (3.3 years, 40.1 months).
Results: The primary outcome of revascularisation in an artery with a previously
negative FFR occurred in 72 patients (9.1%, 86 arteries:10.4%). The annual revas-
cularisation rate was 2.9% at 1 year, 4.1% at 2 years, 2.4% at 3 years, 0.94% at 4
years. The indication for revascularisation was stable angina in 44% (n¼34), unstable
angina in 42% (n¼32) and MI 14% (n¼11). The rate of MI across the cohort was
1.45%(11/788) - all of these patients subsequently underwent revascularisation with
PCI, none requiring CABG. The all cause mortality rate across the cohort was 6%
(n¼47), and there was no signiﬁcant difference observed between the groups that did
and did not undergo revascularisation in either all cause (6.9% vs.5.8%;p¼N.S) or
cardiac mortality (4.1% vs. 2.2%;p¼N.S.).
Conclusions: In a large real world cohort of patients demonstration of a FFR >0.8 in
a native, untreated coronary artery is associated with a low rate of revascularisation,
MI or cardiac death at up to 4 years. This is the oldest population that has been
evaluated with FFR, which may account for the higher all cause mortality rate
observed, compared to other data. These ﬁndings support the data that have shown
clinical beneﬁt associated with ischemia-guided revascularisation.ber 1, 2013 j TCT Abstracts/POSTER/Physiologic Lesion Assessment
